Chromosomal microarray analysis (CMA) (Cytoscan HD, Thermo Fisher Scientific) revealed monoallelic loss of SMARCB1, and an NGS panel (Oncomine Childhood Cancer Research Assay; Thermo Fisher Scientific) did not identify pathogenic variants in SMARCB1 or SMARCA4. Here, SMARCB1 is linked to cancer.